Oncologix Tech, Inc. announced the appointment of Nikole Jessie as the Director of Marketing and Public Relations. Ms. Jessie will be responsible for the development of marketing strategies for the OCLG subsidiaries products and services, manage public relations, investor relations activities, and will facilitate the branding of Oncologix Tech to its Company's shareholders, investors and customers. Ms. Jessie brings direct expertise in both private and public companies' delivery and execution of marketing programs. Prior to joining the Company, she was the Firm Administrator for Landmark Consulting, LLC.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | -92.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-92.00% | 332K | |
+198.00% | 7.13B | |
+2.19% | 982M | |
+41.91% | 872M | |
+25.43% | 820M | |
+1.77% | 664M | |
+5.92% | 648M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M |
- Stock Market
- Equities
- OCLG Stock
- News Oncologix Tech, Inc.
- Oncologix Tech, Inc. Appoints Nikole Jessie as Director of Marketing and Public Relations